These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10708307)

  • 1. Biodistribution of liposomal 131I-VIP in rat using gamma camera.
    Refai E; Jonsson C; Andersson M; Jacobsson H; Larsson S; Kogner P; Hassan M
    Nucl Med Biol; 1999 Nov; 26(8):931-6. PubMed ID: 10708307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo dynamical distribution of 131I-VIP in the rat studied by gamma-camera.
    Hassan M; Refai E; Andersson M; Schnell PO; Jacobsson H
    Nucl Med Biol; 1994 Aug; 21(6):865-72. PubMed ID: 9234336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalable liposomal formulation for vasoactive intestinal peptide.
    Hajos F; Stark B; Hensler S; Prassl R; Mosgoeller W
    Int J Pharm; 2008 Jun; 357(1-2):286-94. PubMed ID: 18328650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A biodistribution experiment on 125 I-VIP in mice].
    Zhao Y; Yang J
    Hua Xi Yi Ke Da Xue Xue Bao; 1998 Sep; 29(3):281-4. PubMed ID: 10684093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo dynamic distribution of 131I-glucagon-like peptide-1 (7-36) amide in the rat studied by gamma camera.
    Hassan M; Eskilsson A; Nilsson C; Jonsson C; Jacobsson H; Refai E; Larsson S; Efendic S
    Nucl Med Biol; 1999 May; 26(4):413-20. PubMed ID: 10382845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats.
    Dufes C; Olivier JC; Gaillard F; Gaillard A; Couet W; Muller JM
    Int J Pharm; 2003 Apr; 255(1-2):87-97. PubMed ID: 12672605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive intestinal peptide encapsulated in liposomes: effects on systemic arterial blood pressure.
    Gao XP; Noda Y; Rubinstein I; Paul S
    Life Sci; 1994; 54(15):PL247-52. PubMed ID: 8152324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of radioiodinated antisense oligonuclide mediated by VIP receptor.
    Ou X; Tan T; He L; Li Y; Li J; Kuang A
    Cancer Gene Ther; 2005 Mar; 12(3):313-20. PubMed ID: 15578065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles.
    Wernig K; Griesbacher M; Andreae F; Hajos F; Wagner J; Mosgoeller W; Zimmer A
    J Control Release; 2008 Sep; 130(2):192-8. PubMed ID: 18601963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal vasoactive intestinal peptide for lung application: protection from proteolytic degradation.
    Stark B; Andreae F; Mosgoeller W; Edetsberger M; Gaubitzer E; Koehler G; Prassl R
    Eur J Pharm Biopharm; 2008 Sep; 70(1):153-64. PubMed ID: 18555674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular and systemic bio-distribution of rhodamine-conjugated liposomes loaded with VIP injected into the vitreous of Lewis rats.
    Camelo S; Lajavardi L; Bochot A; Goldenberg B; Naud MC; Fattal E; Behar-Cohen F; de Kozak Y
    Mol Vis; 2007 Dec; 13():2263-74. PubMed ID: 18451986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99mTc-labeled vasoactive intestinal peptide receptor agonist: functional studies.
    Pallela VR; Thakur ML; Chakder S; Rattan S
    J Nucl Med; 1999 Feb; 40(2):352-60. PubMed ID: 10025846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A pharmacokinetic study of 125I-VIP in rat].
    Li Q; Tan T
    Hua Xi Yi Ke Da Xue Xue Bao; 1998 Jun; 29(2):140-2. PubMed ID: 10684001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal peptide receptor scintigraphy.
    Virgolini I; Kurtaran A; Raderer M; Leimer M; Angelberger P; Havlik E; Li S; Scheithauer W; Niederle B; Valent P
    J Nucl Med; 1995 Oct; 36(10):1732-9. PubMed ID: 7562036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of vasoactive intestinal peptide with polymer-grafted liposomes: structural aspects for pulmonary delivery.
    Stark B; Debbage P; Andreae F; Mosgoeller W; Prassl R
    Biochim Biophys Acta; 2007 Mar; 1768(3):705-14. PubMed ID: 17204237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of dry powder inhalation system of novel vasoactive intestinal peptide (VIP) analogue for pulmonary administration.
    Ohmori Y; Onoue S; Endo K; Matsumoto A; Uchida S; Yamada S
    Life Sci; 2006 Jun; 79(2):138-43. PubMed ID: 16458931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VIP grafted sterically stabilized liposomes for targeted imaging of breast cancer: in vivo studies.
    Dagar S; Krishnadas A; Rubinstein I; Blend MJ; Onyüksel H
    J Control Release; 2003 Aug; 91(1-2):123-33. PubMed ID: 12932644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis.
    Camelo S; Lajavardi L; Bochot A; Goldenberg B; Naud MC; Brunel N; Lescure B; Klein C; Fattal E; Behar-Cohen F; de Kozak Y
    J Ocul Pharmacol Ther; 2009 Feb; 25(1):9-21. PubMed ID: 19232006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and distribution of liposomal busulfan in the rat: a new formulation for intravenous administration.
    Hassan M; Hassan Z; Nilsson C; Rehim MA; Kumlien S; Elfsson B; Kållberg N
    Cancer Chemother Pharmacol; 1998; 42(6):471-8. PubMed ID: 9788573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-targeted niosomes deliver vasoactive intestinal peptide (VIP) to the brain.
    Dufes C; Gaillard F; Uchegbu IF; Schätzlein AG; Olivier JC; Muller JM
    Int J Pharm; 2004 Nov; 285(1-2):77-85. PubMed ID: 15488681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.